Gerresheimer to Showcase Vials and Filling Performance at CPhI Worldwide

The Gx Elite vials have set new standards for Type 1 borosilicate glass vials. They are the result of comprehensive optimisation measures in the conversion process, which have focused on designing out the risk to create product flaws during production, including the removal of all glass-to-glass or glass-to-metal-contact beginning with the tubing material all the way through final packaging. The chemical composition of the borosilicate glass still stays the same.

Gerresheimer will be showcasing Gx Elite vials at booth 4C30 at CPhI in Madrid, Spain, from 9 October 9 to 11 October.

The best in its class

Sales director of Europe tubular glass converting at Gerresheimer Hans-Ulrich Pieper said: “The Gx Elite vials are the result of several years of careful product development and our customers are really impressed with them too.”

The highly shatter-resistant vials are durable and free of cosmetic defects. They also have an incredibly robust structure, while their resistance to delamination protects the drug inside.

Simple handling and a range of packaging options ensure that Gx Elite vials can be supplied for end-to-end use on various filling lines. This cuts costs while improving quality, as countless past and ongoing tests by notable customers have shown.

Intelligent defect recognition

All of Gerresheimer’s tubular glass plants that produce vials work with standardised monitoring, inspection, and packaging technologies, which essentially comprise the Gx G3 and Gx RHOC systems.

The inspection systems are developed in-house and form part of a close-knit testing system that ensures the highest precision and quality assurance in line with the latest standards. Complete with modern HD cameras, the Gx G3 inspection system makes sure that cosmetic defects are identified reliably.

The intelligent software detects and classifies the defects in a few fractions of a second, while the Gx RHOC system ensures dimensional quality with HD matrix cameras and a hypercetric ID camera.

Injection vials set the benchmark for primary packaging for parenteral drugs. Gerresheimer’s vials come in all sizes and comply with the relevant international standards and pharmacopoeias. The company’s range includes solutions for bioengineered drugs and other specialist pharmaceuticals.

More About This Company